B3281004 - Pfizer Extension Study

• Research type

  Research Study

• Full title

  EXTENSION STUDY EVALUATING TREATMENT WITH PF-05280586 VERSUS RITUXIMAB IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO HAVE PARTICIPATED IN OTHER PF-05280586 CLINICAL TRIALS

• IRAS ID

  112649

• Contact name

  Paul Emery

• Contact email

  p.emery@leeds.ac.uk

• Sponsor organisation

  Pfizer Inc., 235 East 42nd Street, New York, NY 10017

• Eudract number

  2012-003223-38

• Clinicaltrials.gov Identifier

  NCT01643928

• REC name

  London - Fulham Research Ethics Committee

• REC reference

  13/LO/0419

• Date of REC Opinion

  14 May 2013

• REC opinion

  Further Information Favourable Opinion